<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, some clinician‐researchers (and policy‐makers who promote such strategies) may promote nonpharmacologic approaches such as “proning” to support the management of pregnant patients with hypoxia from Covid‐19, as the prone posture has demonstrated some benefit for nonpregnant patients.
 <xref rid="eahr500060-bib-0030" ref-type="ref">
  <sup>30</sup>
 </xref> The approach entails the patient either turning herself or being turned prone so that she is lying on her stomach. However, because of the size of the gravid uterus and the potential for vascular compression in specific positions, this is not a reasonable approach for women in the second and third trimesters of pregnancy, stages in which the effects of Covid‐19 may be most severe for a mother and fetus.
 <xref rid="eahr500060-bib-0031" ref-type="ref">
  <sup>31</sup>
 </xref> Thus, management approaches that might seem to minimize risks to pregnant women and their fetuses may, in fact, introduce additional harms if researchers and policy‐makers do not recognize or address the special complexities of pregnant patients as study participants.
</p>
